What is Phenotype Screening?
Phenotype Screening Corporation is a prominent player in the agriculture innovation sector, dedicated to enhancing crop production and protection through the strategic application of science and technology. The company excels in providing custom technology and services, with a particular emphasis on induced expression phenotyping. This advanced methodology allows clients, including leading agricultural enterprises, to gain critical insights into plant responses to various challenges such as abiotic stress, pathogen control, and nutrient uptake. Since its inception in 2004, Phenotype Screening has been instrumental in delivering data-driven intelligence on the effects of agricultural treatments on plant gene expression and overall development, positioning itself as a pioneer in its field.
How much funding has Phenotype Screening raised?
Phenotype Screening has raised a total of $21K across 1 funding round:
Debt
$21K
Debt (2021): $21K with participation from PPP
Key Investors in Phenotype Screening
PPP
Public-Private Partnership
What's next for Phenotype Screening?
With the recent influx of substantial expansion capital, Phenotype Screening Corporation is poised for accelerated growth and market penetration. The company's strategic focus on advancing crop production and protection through sophisticated phenotyping techniques, particularly in areas like abiotic stress tolerance and pathogen control, aligns with the increasing global demand for sustainable and efficient agricultural practices. This investment is expected to fuel further research and development, enhance service offerings, and potentially expand their client base within the innovative agriculture companies sector. The company's trajectory suggests a continued commitment to leveraging cutting-edge science and technology to address key challenges in modern farming.
See full Phenotype Screening company page
